Lab medicine increasingly uses ‘on-a-chip’ solutions that replicate tissues, organ systems, or even an entire patient’s body. Michael Shuler, one of the pioneers of this technology, goes into details. Read more about prevention of blood culture contaminations and AI to find the genetic ‘imprint’ a Covid-19 infection leaves behind in the body!
Article • Personalised medicine
'Body-on-a-chip' technology boosts drug development
Integrating laboratory functions on a microchip circuit is helping improve the cost-effectiveness of drug development. So-called ‘lab-on-a-chip’ or ‘human-on-a-chip’ technology can highlight which treatments may, or may not, work before ...
 |
Article • PreventionSpecimen diversion devices lower blood culture contaminationBlood cultures are important laboratory tests to diagnose serious infections. Contamination is a constant concern – a patient could be misdiagnosed due to a false-positive test. Initial specimen diversion (ISD) could radically change this. |
 |
Article • Detecting CoronavirusAI vs. Covid-19: ‘Barcode’ brings quicker test resultsWhen patients are admitted to a hospital emergency room (ER) it is immediately vital to determine whether s/he has Covid-19. However, with a regular PCR test a result can take up to a few hours. Thus, initially, the patient must be isolated. During ... |
 |
Article • Antibiotic resistanceFive-minute MRSA detection with aptasensor swabsAn international research team from Saudi Arabia, Germany, and Jordan has developed a novel pathogen aptasensor swab designed to qualitatively detect, within five minutes, any methicillin-resistant Staphylococcus aureus (MRSA) contamination that ... |
 |
Article • Workflow optimisationThe potential of AI in breast imaging efficiencyThe contribution of Artificial intelligence (AI) has great potential in breast imaging efficiency, Professor Linda Moy MD told attendees at the 2021 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium this ... |
 |
Article • Innovation in interventionThe promise and reality about AI for interventional oncologyIs artificial intelligence (AI) technology ready to be utilized as a clinical tool by interventional oncologists? Not yet, but when it is, AI technology’s clinical impact may be as profound as advanced imaging is today, two leading experts agree. |
 |
Article • Fighting cancer togetherNew interdisciplinary approaches to intervention & immuno-oncologyOver recent years interventional oncology (IO), as a subspecialty of interventional radiology, has become a standard component of many cancer therapies. The broad range of minimally invasive methods – and their results – are often comparable to ... |
You are receiving this email because you subscribed to our newsletter on healthcare-in-europe If you don’t want to receive this newsletter anymore, click here to unsubscribe. Keep up-to-date on the latest news from all hospital-related fields! Copyright © 2024 mgo fachverlage GmbH & Co. KG. E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany |
   |